Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Raed Behbehani, Abdullah Ali & Ashraf Al-Moosa. (2022) Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies. Neuro-Ophthalmology 46:4, pages 220-226.
Read now
Read now
Shuhui Wang, Iva Breskovska, Shreya Gandhy, Anna Rostedt Punga, Jeffery T. Guptill & Henry J. Kaminski. (2018) Advances in autoimmune myasthenia gravis management. Expert Review of Neurotherapeutics 18:7, pages 573-588.
Read now
Read now
Articles from other publishers (42)
Yajun Mu, Xin Huang, Yuanting Yang, Ziqing Huang, Jiaxin Chen, Shiyin Li, Yuying Dong, Fangyuan Chen, Rijia Zhang, Jian Chen, Huiyu Feng & Qing Zhou. (2024) Study of serum exosome miRNA as a biomarker for early onset adult ouclar myastthenia gravis. Gene 896, pages 148034.
Crossref
Crossref
Minghua Shi, Zhuneng Lu, Aijiao Qin, Jing Cheng, Simin Chen & Yiqiao Xing. (2024) A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis. BMC Ophthalmology 24:1.
Crossref
Crossref
Laura Wilson & Helen Davis. (2023) The Role of Thymoma and Thymic Hyperplasia as Prognostic Risk Factors for Secondary Generalisation in Adults with Ocular Myasthenia Gravis: A Systematic Narrative Review. British and Irish Orthoptic Journal 19:1, pages 108-119.
Crossref
Crossref
Clarissa Ern Hui Fang, Desta Bokre & Sui Hsien Wong. (2023) Clinical Characteristics Associated With Secondary Generalization in Patients With Ocular Myasthenia Gravis. Neurology 101:16.
Crossref
Crossref
Yong Hoon Seo, Won Jin Yang & Shin Yeop Oh. (2023) Ophthalmologic Manifestations of Ocular Myasthenia Gravis. Journal of the Korean Ophthalmological Society 64:10, pages 957-965.
Crossref
Crossref
Jorge L. Almodovar & Anahit Mehrabyan. (2023) Disease-Based Prognostication: Myasthenia Gravis. Seminars in Neurology 43:05, pages 799-806.
Crossref
Crossref
Neşe Çelebisoy, Asim Orujov, Fidan Balayeva, Hüseyin Nezih Özdemir, Ayşın Kısabay Ak & Figen Gökçay. (2022) Prognostic predictors of remission in ocular myasthenia gravis. Acta Neurologica Belgica 123:5, pages 1927-1932.
Crossref
Crossref
Zhuajin Bi, Huizhen Ge, Qing Zhang, Huajie Gao, Mengge Yang, Jiayang Zhan, Jing Lin, Mengcui Gui, Yue Li, Suqiong Ji, Yayun Cao & Bitao Bu. (2023) Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort. Pediatric Neurology 146, pages 31-39.
Crossref
Crossref
I. Díaz-Maroto, J. García-García, P.A. Sánchez-Ayaso, C. Alcahut-Rodríguez, E. González-Villar, J.M. Pardal-Fernández & T. Segura. (2023) Ocular myasthenia gravis and risk factors for developing a secondary generalisation: description of a Spanish series. Neurología (English Edition) 38:4, pages 229-235.
Crossref
Crossref
I. Díaz-Maroto, J. García-García, P.A. Sánchez-Ayaso, C. Alcahut-Rodríguez, E. González-Villar, J.M. Pardal-Fernández & T. Segura. (2023) Miastenia gravis ocular y factores asociados al desarrollo de una generalización secundaria: descripción de una serie española. Neurología 38:4, pages 229-235.
Crossref
Crossref
Claudia Vinciguerra, Salvatore Iacono, Liliana Bevilacqua, Annamaria Landolfi, Giuseppe Piscosquito, Federica Ginanneschi, Giuseppe Schirò, Vincenzo Di Stefano, Filippo Brighina, Paolo Barone & Carmela Rita Balistreri. (2023) Sex differences in neuromuscular disorders. Mechanisms of Ageing and Development 211, pages 111793.
Crossref
Crossref
Zhuajin Bi, Yayun Cao, Mengcui Gui, Jing Lin, Qing Zhang, Yue Li, Suqiong Ji & Bitao Bu. (2022) Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis. Neurological Sciences 44:4, pages 1383-1391.
Crossref
Crossref
Parinee Kemchoknatee, Anyarak Armornpetchsathaporn, Duanghathai Tangon & Thansit Srisombut. (2023) Age of onset and factors affecting treatment responses in ocular myasthenia gravis. International Ophthalmology 43:8, pages 2777-2785.
Crossref
Crossref
Shiyin Li, Jiaxin Chen, Xu Yang, Xin Huang, Haiyan Wang & Huiyu Feng. (2023) Anti-dsDNA Is Associated with Favorable Prognosis in Myasthenia Gravis: A Retrospective Study. Acta Neurologica Scandinavica 2023, pages 1-11.
Crossref
Crossref
Tomoko Narita, Shunya Nakane, Akiko Nagaishi, Naoya Minami, Masaaki Niino, Naoki Kawaguchi, Hiroyuki Murai, Jun-ichi Kira, Jun Shimizu, Kazuo Iwasa, Hiroaki Yoshikawa, Yuki Hatanaka, Masahiro Sonoo, Yuko Shimizu & Hidenori Matsuo. (2023) Immunotherapy for ocular myasthenia gravis: an observational study in Japan. Therapeutic Advances in Neurological Disorders 16.
Crossref
Crossref
Antoine Guéguen, Benoit Hijazi, Kevin Zuber, Romain Deschamps, Cedric Lamirel, Catherine Vignal-Clermont & Olivier Gout. (2022) Generalization of ocular myasthenia gravis 10 years after onset. Journal of Neurology 269:12, pages 6597-6604.
Crossref
Crossref
Ikjae Lee, Jesse D. Schold, Michael K. Hehir, Benjamin Claytor, Nicholas Silvestri & Yuebing Li. (2022) Re: Diagnosing myasthenia gravis in older patients: Comments and observations. Muscle & Nerve 66:4.
Crossref
Crossref
Jinwei Zhang, Zeyang Zhang, Hui Zhang, Yuantao Cui, Yuan Chen, Peng Lv & Peng Zhang. (2022) Thymectomy in ocular myasthenia gravis—prognosis and risk factors analysis. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Zhe Ruan, Chao Sun, Yanlin Lang, Feng Gao, Rongjing Guo, Quan Xu, Liping Yu, Songdi Wu, Tao Lei, Yu Liu, Min Zhang, Huanhuan Li, Yonglan Tang, Ting Gao, Yanwu Gao, Xiaodan Lu, Zhuyi Li & Ting Chang. (2022) Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis. Frontiers in Immunology 13.
Crossref
Crossref
Ayşın Kısabay, Hüseyin Nezih Özdemir, Figen Gökçay & Neşe Çelebisoy. (2021) Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic. Acta Neurologica Belgica 122:2, pages 337-344.
Crossref
Crossref
Rong-Jing Guo, Ting Gao, Zhe Ruan, Hong-Yu Zhou, Feng Gao, Quan Xu, Li-Ping Yu, Song-Di Wu, Tao Lei, Huan-Huan Li, Chao Sun, Min Zhang, Yan-Wu Gao, Xiao-Dan Lu, Yong-Lan Tang, Bao-Li Tang, Fei-Yan Huo, Ying Zhu, Zhu-Yi Li & Ting Chang. (2021) Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study. Neurology and Therapy 11:1, pages 73-86.
Crossref
Crossref
Yesha S. Shah, Amanda D. Henderson & Andrew R. Carey. (2021) Effect of Initial Prednisone Dosing on Ocular Myasthenia Gravis Control. Journal of Neuro-Ophthalmology 41:4, pages e622-e626.
Crossref
Crossref
Juthamat Witthayaweerasak, Narisa Rattanalert & Nipat Aui-aree. (2021) Prognostic factors for conversion to generalization in ocular myasthenia gravis. Medicine 100:19, pages e25899.
Crossref
Crossref
Benjamin Claytor & Yuebing Li. (2020) Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Muscle & Nerve 63:5, pages 631-639.
Crossref
Crossref
Ki Hoon Kim, Seung Woo Kim & Ha Young Shin. (2021) Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis. Journal of Clinical Neurology 17:2, pages 265.
Crossref
Crossref
Kevin R. Keene, Luc van Vught, Nienke M. van de Velde, Isabeau A. Ciggaar, Irene C. Notting, Stijn W. Genders, Jan J.G.M. Verschuuren, Martijn R. Tannemaat, Hermien E. Kan & Jan‐Willem M. Beenakker. (2020) The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy. NMR in Biomedicine 34:1.
Crossref
Crossref
Jiaqi Ding, Sijia Zhao, Kaixi Ren, Dan Dang, Hongzeng Li, Fang Wu, Min Zhang, Zhuyi Li & Jun Guo. (2020) Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China. BMC Neurology 20:1.
Crossref
Crossref
Yoshihiko Isshiki, Osamu Mimura & Fumi Gomi. (2020) Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis. Japanese Journal of Ophthalmology 64:6, pages 628-634.
Crossref
Crossref
Sawsan Alabbad, Mohanad AlGaeed, Patricia Sikorski & Henry J. Kaminski. (2020) Monoclonal Antibody-Based Therapies for Myasthenia Gravis. BioDrugs 34:5, pages 557-566.
Crossref
Crossref
John Morren & Yuebing Li. (2020) Maintenance immunosuppression in myasthenia gravis, an update. Journal of the Neurological Sciences 410, pages 116648.
Crossref
Crossref
Andrew T. Melson, Collin M. McClelland & Michael S. Lee. (2020) Ocular myasthenia gravis: updates on an elusive target. Current Opinion in Neurology 33:1, pages 55-61.
Crossref
Crossref
Xuelin Feng, Xiao Huan, Chong Yan, Jie Song, Jun Lu, Lei Zhou, Hui Wu, Kai Qiao, Jiahong Lu, Jianying Xi, Sushan Luo & Chongbo Zhao. (2020) Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China. European Neurology 83:2, pages 182-188.
Crossref
Crossref
Supanut Apinyawasisuk, Yuda Chongpison, Chawin Thitisaksakul & Supharat Jariyakosol. (2020) Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody. American Journal of Ophthalmology 209, pages 10-17.
Crossref
Crossref
Cheng-Che Chou, I-Chen Su, I-Jun Chou, Jainn-Jim Lin, Shih-Yun Lan, Yi-Shan Wang, Shu-Sing Kong, Yun-Ju Chen, Meng-Ying Hsieh, Po-Cheng Hung, Huei-Shyong Wang, Min-Liang Chou & Kuang-Lin Lin. (2019) Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study. BMC Neurology 19:1.
Crossref
Crossref
Loulwah Mukharesh & Henry J. Kaminski. (2019) A Neurologist’s Perspective on Understanding Myasthenia Gravis. Thoracic Surgery Clinics 29:2, pages 133-141.
Crossref
Crossref
P. Merino Sanz, I. del Cerro Pérez, G. Alan Peinado & P. Gómez de Liaño Sánchez. (2019) Causes and surgical treatment of diplopia and strabismus secondary to myasthenia gravis. Archivos de la Sociedad Española de Oftalmología (English Edition) 94:3, pages 107-113.
Crossref
Crossref
P. Merino Sanz, I. del Cerro Pérez, G. Alan Peinado & P. Gómez de Liaño Sánchez. (2019) Causas y tratamiento quirúrgico de la diplopía y estrabismo en la miastenia gravis. Archivos de la Sociedad Española de Oftalmología 94:3, pages 107-113.
Crossref
Crossref
Liis Sabre, Paul Maddison, Sui H. Wong, Girija Sadalage, Philip A. Ambrose, Gordon T. Plant & Anna R. Punga. (2019) miR‐30e‐5p as predictor of generalization in ocular myasthenia gravis. Annals of Clinical and Translational Neurology 6:2, pages 243-251.
Crossref
Crossref
. (2019) Treatment of Ocular Myasthenia Gravis. Asia-Pacific Journal of Ophthalmology.
Crossref
Crossref
Feng Li, Benjamin Hotter, Marc Swierzy, Mahmoud Ismail, Andreas Meisel & Jens-C. Rückert. (2018) Generalization after ocular onset in myasthenia gravis: a case series in Germany. Journal of Neurology 265:12, pages 2773-2782.
Crossref
Crossref
Giuliana Galassi, Marco Mazzoli, Alessandra Ariatti, Shaniko Kaleci, Franco Valzania & Paolo F. Nichelli. (2018) Antibody profile may predict outcome in ocular myasthenia gravis. Acta Neurologica Belgica 118:3, pages 435-443.
Crossref
Crossref
Xin Huang, Yingkai Li, Huiyu Feng, Pei Chen & Weibin Liu. (2018) Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China. Frontiers in Neurology 9.
Crossref
Crossref